PAPER Barrett LE, Sul JY, Takano H, Van Bockstaele EJ, Haydon PG, Eberwine JH

Region-directed phototransfection reveals the functional significance of a dendritically synthesized transcription factor.

Nat Methods. 2006 Jun;3(6):455-60. PubMed: 16721379

CD14 MY4+ monocytes (322A-1)

ANTIBODY monoclonal 322A-1 manufacturer Cat# 6603511<br />Reference:<br /><a href="/papers/cd14-and-toll-receptors-2-and-4-are-required-fibrillar-abeta-stimulated-microglial-activation" target="_new">Reed-Geaghan, 2009</a&g

Amyloid β [x-42] and Aβ [x-40]

ANTIBODY kit manufacturer cat# INNO-BIA<br />blood ß-amyloid kit<br /><a href="http://www.innogenetics.com/documenten/BIA_plasma_leaflet.pdf" target="_new">Leaflet</a><br />References:<br /><a href="/

Amyloid β [1-42] and Aβ [1-40]

ANTIBODY kit manufacturer cat# 80933<br /> INNO-BIA<br />blood ß-amyloid kit<br /><a href="http://www.innogenetics.com/documenten/BIA_plasma_leaflet.pdf" target="_new">Leaflet</a><br />References:<br />

Mireia Coma Camprodon

Barcelona, Spain

PAPER da Costa RF, Martinez AM, Ferreira ST

2,4-Dinitrophenol blocks neurodegeneration and preserves sciatic nerve function after trauma.

J Neurotrauma. 2010 May;27(5):829-41. PubMed: 20143955

Dimebon for HD—A Hint of Cognitive Benefit?

RESEARCH NEWS 2010-02-12 Research News This story was updated on 15 February 2010. 12 February 2010. The results of the first U.S. Phase 2 trial for Dimebon in Huntington disease are finally out in print. The February Archives of Neurology carries the report from the Huntington S

CSF Biomarkers Track With Atrophy, Cognition in Normal Aging

RESEARCH NEWS 2010-02-12 Research News When judging the utility of cerebrospinal fluid biomarkers in Alzheimer disease, it may be less a question of if, but rather when and in whom. In this week’s Journal of Neuroscience, scientists report analysis of CSF biomarkers and brain atr

Toxic Elk-1 Phosphoform Found in AD, HD, Lewy Body Disease Inclusions

RESEARCH NEWS 2010-02-12 Research News The protein aggregates that brew discord in several neurodegenerative diseases may have some troublemakers in common. One could be Elk-1, a transcription factor that has been shown to trigger cell death when expressed within neuronal dendrit

PAPER Prior M, Shi Q, Hu X, He W, Levey A, Yan R

RTN/Nogo in forming Alzheimer's neuritic plaques.

Neurosci Biobehav Rev. 2010 Jul;34(8):1201-6. PubMed: 20144652

PAPER Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.

Neurochem Int. 2010 Nov;57(4):375-82. PubMed: 20144675

PAPER Ghosh A, Dutt A

Utilisation behaviour in frontotemporal dementia.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):154-6. PubMed: 20145027

PAPER McGuinness B, Barrett SL, Craig D, Lawson J, Passmore AP

Attention deficits in Alzheimer's disease and vascular dementia.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):157-9. PubMed: 20145028

PAPER Vickland V, McDonnell G, Werner J, Draper B, Low LF, Brodaty H

A computer model of dementia prevalence in Australia: foreseeing outcomes of delaying dementia onset, slowing disease progression, and eradicating dementia types.

Dement Geriatr Cogn Disord. 2010;29(2):123-30. PubMed: 20145398

PAPER Fuentes LJ, Fernández PJ, Campoy G, Antequera MM, García-Sevilla J, Antúnez C

Attention network functioning in patients with dementia with Lewy bodies and Alzheimer's disease.

Dement Geriatr Cogn Disord. 2010;29(2):139-45. PubMed: 20145400